Report Overview
Report Overview
The parathyroid glands are four small glands located in the neck that produce parathyroid hormone (PTH), which regulates the levels of calcium and phosphorus in the body. There are several drugs that can affect the function of the parathyroid gland or the levels of PTH in the body.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Parathyroid Glands and Related Medicines market size was estimated at USD 1446.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Parathyroid Glands and Related Medicines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Parathyroid Glands and Related Medicines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Parathyroid Glands and Related Medicines market.
Global Parathyroid Glands and Related Medicines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CTTQ
Roche
Future Health Pharma
KPC Pharmaceuticals
Teva Pharmaceutical
Nantong Huashan Pharmaceutical
Teijin Pharma
Kyowa Kirin
Cheplapharm Arzneimittel
Jiangsu Hengrui Pharmaceuticals
Novartis
Chongqing Yaoyou Pharmaceutical
AbbVie
Hebei Renhe Yikang Pharmaceutical
Market Segmentation (by Type)
Calcitriol
Alfacalcidol
Salmon Calcitonin
Paricalcitol
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parathyroid Glands and Related Medicines Market
Overview of the regional outlook of the Parathyroid Glands and Related Medicines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parathyroid Glands and Related Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Parathyroid Glands and Related Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Parathyroid Glands and Related Medicines
- 1.2 Key Market Segments
- 1.2.1 Parathyroid Glands and Related Medicines Segment by Type
- 1.2.2 Parathyroid Glands and Related Medicines Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Parathyroid Glands and Related Medicines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Parathyroid Glands and Related Medicines Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Parathyroid Glands and Related Medicines Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Parathyroid Glands and Related Medicines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Parathyroid Glands and Related Medicines Product Life Cycle
- 3.3 Global Parathyroid Glands and Related Medicines Sales by Manufacturers (2020-2025)
- 3.4 Global Parathyroid Glands and Related Medicines Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Parathyroid Glands and Related Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Parathyroid Glands and Related Medicines Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Parathyroid Glands and Related Medicines Market Competitive Situation and Trends
- 3.8.1 Parathyroid Glands and Related Medicines Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Parathyroid Glands and Related Medicines Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Parathyroid Glands and Related Medicines Industry Chain Analysis
- 4.1 Parathyroid Glands and Related Medicines Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Parathyroid Glands and Related Medicines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Parathyroid Glands and Related Medicines Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Parathyroid Glands and Related Medicines Market
- 5.7 ESG Ratings of Leading Companies
- 6 Parathyroid Glands and Related Medicines Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Parathyroid Glands and Related Medicines Sales Market Share by Type (2020-2025)
- 6.3 Global Parathyroid Glands and Related Medicines Market Size by Type (2020-2025)
- 6.4 Global Parathyroid Glands and Related Medicines Price by Type (2020-2025)
- 7 Parathyroid Glands and Related Medicines Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Parathyroid Glands and Related Medicines Market Sales by Application (2020-2025)
- 7.3 Global Parathyroid Glands and Related Medicines Market Size (M USD) by Application (2020-2025)
- 7.4 Global Parathyroid Glands and Related Medicines Sales Growth Rate by Application (2020-2025)
- 8 Parathyroid Glands and Related Medicines Market Sales by Region
- 8.1 Global Parathyroid Glands and Related Medicines Sales by Region
- 8.1.1 Global Parathyroid Glands and Related Medicines Sales by Region
- 8.1.2 Global Parathyroid Glands and Related Medicines Sales Market Share by Region
- 8.2 Global Parathyroid Glands and Related Medicines Market Size by Region
- 8.2.1 Global Parathyroid Glands and Related Medicines Market Size by Region
- 8.2.2 Global Parathyroid Glands and Related Medicines Market Size by Region
- 8.3 North America
- 8.3.1 North America Parathyroid Glands and Related Medicines Sales by Country
- 8.3.2 North America Parathyroid Glands and Related Medicines Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Parathyroid Glands and Related Medicines Sales by Country
- 8.4.2 Europe Parathyroid Glands and Related Medicines Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Parathyroid Glands and Related Medicines Sales by Region
- 8.5.2 Asia Pacific Parathyroid Glands and Related Medicines Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Parathyroid Glands and Related Medicines Sales by Country
- 8.6.2 South America Parathyroid Glands and Related Medicines Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Parathyroid Glands and Related Medicines Sales by Region
- 8.7.2 Middle East and Africa Parathyroid Glands and Related Medicines Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Parathyroid Glands and Related Medicines Sales by Region
- 9 Parathyroid Glands and Related Medicines Market Production by Region
- 9.1 Global Production of Parathyroid Glands and Related Medicines by Region(2020-2025)
- 9.2 Global Parathyroid Glands and Related Medicines Revenue Market Share by Region (2020-2025)
- 9.3 Global Parathyroid Glands and Related Medicines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Parathyroid Glands and Related Medicines Production
- 9.4.1 North America Parathyroid Glands and Related Medicines Production Growth Rate (2020-2025)
- 9.4.2 North America Parathyroid Glands and Related Medicines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Parathyroid Glands and Related Medicines Production
- 9.5.1 Europe Parathyroid Glands and Related Medicines Production Growth Rate (2020-2025)
- 9.5.2 Europe Parathyroid Glands and Related Medicines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Parathyroid Glands and Related Medicines Production (2020-2025)
- 9.6.1 Japan Parathyroid Glands and Related Medicines Production Growth Rate (2020-2025)
- 9.6.2 Japan Parathyroid Glands and Related Medicines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Parathyroid Glands and Related Medicines Production (2020-2025)
- 9.7.1 China Parathyroid Glands and Related Medicines Production Growth Rate (2020-2025)
- 9.7.2 China Parathyroid Glands and Related Medicines Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 CTTQ
- 10.1.1 CTTQ Basic Information
- 10.1.2 CTTQ Parathyroid Glands and Related Medicines Product Overview
- 10.1.3 CTTQ Parathyroid Glands and Related Medicines Product Market Performance
- 10.1.4 CTTQ Business Overview
- 10.1.5 CTTQ SWOT Analysis
- 10.1.6 CTTQ Recent Developments
- 10.2 Roche
- 10.2.1 Roche Basic Information
- 10.2.2 Roche Parathyroid Glands and Related Medicines Product Overview
- 10.2.3 Roche Parathyroid Glands and Related Medicines Product Market Performance
- 10.2.4 Roche Business Overview
- 10.2.5 Roche SWOT Analysis
- 10.2.6 Roche Recent Developments
- 10.3 Future Health Pharma
- 10.3.1 Future Health Pharma Basic Information
- 10.3.2 Future Health Pharma Parathyroid Glands and Related Medicines Product Overview
- 10.3.3 Future Health Pharma Parathyroid Glands and Related Medicines Product Market Performance
- 10.3.4 Future Health Pharma Business Overview
- 10.3.5 Future Health Pharma SWOT Analysis
- 10.3.6 Future Health Pharma Recent Developments
- 10.4 KPC Pharmaceuticals
- 10.4.1 KPC Pharmaceuticals Basic Information
- 10.4.2 KPC Pharmaceuticals Parathyroid Glands and Related Medicines Product Overview
- 10.4.3 KPC Pharmaceuticals Parathyroid Glands and Related Medicines Product Market Performance
- 10.4.4 KPC Pharmaceuticals Business Overview
- 10.4.5 KPC Pharmaceuticals Recent Developments
- 10.5 Teva Pharmaceutical
- 10.5.1 Teva Pharmaceutical Basic Information
- 10.5.2 Teva Pharmaceutical Parathyroid Glands and Related Medicines Product Overview
- 10.5.3 Teva Pharmaceutical Parathyroid Glands and Related Medicines Product Market Performance
- 10.5.4 Teva Pharmaceutical Business Overview
- 10.5.5 Teva Pharmaceutical Recent Developments
- 10.6 Nantong Huashan Pharmaceutical
- 10.6.1 Nantong Huashan Pharmaceutical Basic Information
- 10.6.2 Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Product Overview
- 10.6.3 Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Product Market Performance
- 10.6.4 Nantong Huashan Pharmaceutical Business Overview
- 10.6.5 Nantong Huashan Pharmaceutical Recent Developments
- 10.7 Teijin Pharma
- 10.7.1 Teijin Pharma Basic Information
- 10.7.2 Teijin Pharma Parathyroid Glands and Related Medicines Product Overview
- 10.7.3 Teijin Pharma Parathyroid Glands and Related Medicines Product Market Performance
- 10.7.4 Teijin Pharma Business Overview
- 10.7.5 Teijin Pharma Recent Developments
- 10.8 Kyowa Kirin
- 10.8.1 Kyowa Kirin Basic Information
- 10.8.2 Kyowa Kirin Parathyroid Glands and Related Medicines Product Overview
- 10.8.3 Kyowa Kirin Parathyroid Glands and Related Medicines Product Market Performance
- 10.8.4 Kyowa Kirin Business Overview
- 10.8.5 Kyowa Kirin Recent Developments
- 10.9 Cheplapharm Arzneimittel
- 10.9.1 Cheplapharm Arzneimittel Basic Information
- 10.9.2 Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Product Overview
- 10.9.3 Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Product Market Performance
- 10.9.4 Cheplapharm Arzneimittel Business Overview
- 10.9.5 Cheplapharm Arzneimittel Recent Developments
- 10.10 Jiangsu Hengrui Pharmaceuticals
- 10.10.1 Jiangsu Hengrui Pharmaceuticals Basic Information
- 10.10.2 Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Product Overview
- 10.10.3 Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Product Market Performance
- 10.10.4 Jiangsu Hengrui Pharmaceuticals Business Overview
- 10.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
- 10.11 Novartis
- 10.11.1 Novartis Basic Information
- 10.11.2 Novartis Parathyroid Glands and Related Medicines Product Overview
- 10.11.3 Novartis Parathyroid Glands and Related Medicines Product Market Performance
- 10.11.4 Novartis Business Overview
- 10.11.5 Novartis Recent Developments
- 10.12 Chongqing Yaoyou Pharmaceutical
- 10.12.1 Chongqing Yaoyou Pharmaceutical Basic Information
- 10.12.2 Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Product Overview
- 10.12.3 Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Product Market Performance
- 10.12.4 Chongqing Yaoyou Pharmaceutical Business Overview
- 10.12.5 Chongqing Yaoyou Pharmaceutical Recent Developments
- 10.13 AbbVie
- 10.13.1 AbbVie Basic Information
- 10.13.2 AbbVie Parathyroid Glands and Related Medicines Product Overview
- 10.13.3 AbbVie Parathyroid Glands and Related Medicines Product Market Performance
- 10.13.4 AbbVie Business Overview
- 10.13.5 AbbVie Recent Developments
- 10.14 Hebei Renhe Yikang Pharmaceutical
- 10.14.1 Hebei Renhe Yikang Pharmaceutical Basic Information
- 10.14.2 Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Product Overview
- 10.14.3 Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Product Market Performance
- 10.14.4 Hebei Renhe Yikang Pharmaceutical Business Overview
- 10.14.5 Hebei Renhe Yikang Pharmaceutical Recent Developments
- 10.1 CTTQ
- 11 Parathyroid Glands and Related Medicines Market Forecast by Region
- 11.1 Global Parathyroid Glands and Related Medicines Market Size Forecast
- 11.2 Global Parathyroid Glands and Related Medicines Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Parathyroid Glands and Related Medicines Market Size Forecast by Country
- 11.2.3 Asia Pacific Parathyroid Glands and Related Medicines Market Size Forecast by Region
- 11.2.4 South America Parathyroid Glands and Related Medicines Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Parathyroid Glands and Related Medicines by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Parathyroid Glands and Related Medicines Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Parathyroid Glands and Related Medicines by Type (2026-2035)
- 12.1.2 Global Parathyroid Glands and Related Medicines Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Parathyroid Glands and Related Medicines by Type (2026-2035)
- 12.2 Global Parathyroid Glands and Related Medicines Market Forecast by Application (2026-2035)
- 12.2.1 Global Parathyroid Glands and Related Medicines Sales (K MT) Forecast by Application
- 12.2.2 Global Parathyroid Glands and Related Medicines Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Parathyroid Glands and Related Medicines Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings